Clinical trial
A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients
NCT00344409 · Kyowa Kirin Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00344409 |
|---|---|
| Title | A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients |
| Official title | A Double-blind, Placebo Controlled, Randomized Study of KRN321 for the Treatment of Anemia in Cancer Patients |
| Lead sponsor | Kyowa Kirin Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | darbepoetin alfa |
| Enrollment | 200 |
| Start date | Mar 1, 2006 |
| Primary completion | May 1, 2007 |
| First posted | Jun 26, 2006 |
| Last update posted | Aug 31, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: